Cargando…
Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
BACKGROUND: Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up of multiple sclerosis (MS) patients on clinical routine datasets. OBJECTIVE: To determine the feasibility of T2-FLAIR-only measures of lateral ventricular volume (LVV) and salient central...
Autores principales: | Barnett, Michael, Bergsland, Niels, Weinstock-Guttman, Bianca, Butzkueven, Helmut, Kalincik, Tomas, Desmond, Patricia, Gaillard, Frank, van Pesch, Vincent, Ozakbas, Serkan, Rojas, Juan Ignacio, Boz, Cavit, Altintas, Ayse, Wang, Chenyu, Dwyer, Michael G., Yang, Suzie, Jakimovski, Dejan, Kyle, Kain, Ramasamy, Deepa P., Zivadinov, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408519/ https://www.ncbi.nlm.nih.gov/pubmed/34469848 http://dx.doi.org/10.1016/j.nicl.2021.102802 |
Ejemplares similares
-
Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis
por: Dwyer, Michael G., et al.
Publicado: (2017) -
Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI
por: Fuchs, Tom A., et al.
Publicado: (2021) -
Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes
por: Jakimovski, Dejan, et al.
Publicado: (2021) -
Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020) -
Comparative effectiveness of cladribine tablets versus other oral
disease-modifying treatments for multiple sclerosis: Results from MSBase
registry
por: Spelman, Tim, et al.
Publicado: (2022)